Background malaria incidence and parasitemia during the three-dose RTS,S/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malaria

BACKGROUND: RTS,S/AS01 has been recommended by WHO for widespread implementation in medium to high malaria transmission settings. Previous analyses have noted lower vaccine efficacies in higher transmission settings, possibly due to the more rapid development of naturally acquired immunity in the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Griffin J, Gyaase, Stephaney, Goel, Varun, Adu, Bright, Mensah, Benedicta, Essone, Paulin, Dosoo, David, Osei, Musah, Niare, Karamoko, Wiru, Kenneth, Brandt, Katerina, Emch, Michael, Ghansah, Anita, Asante, Kwaku Poku, Mvalo, Tisungane, Agnandji, Selidji Todagbe, Juliano, Jonathan J, Bailey, Jeffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594884/
https://www.ncbi.nlm.nih.gov/pubmed/37872492
http://dx.doi.org/10.1186/s12879-023-08699-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594884/
https://www.ncbi.nlm.nih.gov/pubmed/37872492
http://dx.doi.org/10.1186/s12879-023-08699-7

Ejemplares similares